Pecora Nicole D, Zand Martin S
University of Rochester Medical Center, Rochester, NY, USA.
Department of Medicine, Nephrology (SMD), Clinical & Translational Science Institute, Clinical Research University of Rochester Medical Center, School of Medicine and Dentistry, 601 Elmwood Avenue, Box 675, Rochester, NY 14642, USA.
Clin Lab Med. 2020 Dec;40(4):603-614. doi: 10.1016/j.cll.2020.08.014. Epub 2020 Aug 8.
The entire spectrum of diagnostic testing, from reagent supply to test performance, has been a major focus during the coronavirus disease 2019 (COVID-19) pandemic. The hope for serologic testing is that it will provide both epidemiologic information about seroprevalence as well as individual information about previous infection. This information is particularly helpful for high-risk individuals who may be outside of the viral shedding window, such as children with suspected multisystem inflammatory syndrome. It is not yet understood whether serologic testing can be interpreted in terms of protective immunity. These concerns must be addressed using highly sensitive and specific tests.
从试剂供应到检测执行,整个诊断检测范围一直是2019年冠状病毒病(COVID-19)大流行期间的主要关注点。血清学检测的期望在于,它既能提供有关血清流行率的流行病学信息,也能提供有关既往感染的个体信息。这一信息对于可能处于病毒脱落窗口期之外的高危个体尤为有用,比如疑似多系统炎症综合征的儿童。目前尚不清楚血清学检测是否能从保护性免疫的角度进行解读。必须使用高度灵敏且特异的检测来解决这些问题。